Revenue: The sum of all revenue fields included for a company's operating activities.
Northwest Biotherapeutics, Inc. (NWBO) had Revenue of $1.38M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$1.38M |
$-85.19M |
|
-- |
|
$1.38M |
|
$67.89M |
|
$-66.51M |
|
$-17.27M |
|
$-83.78M |
|
$-83.78M |
|
$-83.78M |
|
$-83.78M |
|
$-83.78M |
|
$-83.78M |
|
$-66.51M |
|
$-62.29M |
|
1.24B |
|
1.24B |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$4.06M |
|
$16.20M |
|
$22.67M |
|
$26.73M |
|
$68.27M |
|
-- |
|
$37.43M |
|
$105.71M |
|
$-94.49M |
|
$-80.90M |
|
$-78.98M |
|
1.33B |
|
| Cash Flow Statement Financials | |
$-57.02M |
|
$-1.01M |
|
$56.78M |
|
$2.13M |
|
$2.17M |
|
$0.05M |
|
$3.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.06 |
|
-- |
|
-- |
|
-- |
|
-0.56 |
|
100.00% |
|
-4812.44% |
|
-4812.44% |
|
-4507.09% |
|
-6062.08% |
|
-6164.40% |
|
$-58.03M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
88.67% |
|
103.56% |
|
-313.45% |
|
106.08% |
|
$-0.06 |
|
$-0.05 |
|
$-0.05 |
|